Documente Academic
Documente Profesional
Documente Cultură
Mabel Vasnaik
Dept of Emergency Medicine
St Johns Medical College Hospital
Overview
Epidemiology
Antisnake venom (ASV) &
complications
Treatment of ASV
reactions
Other supportive
management
Incidence of Snakebite
Globally 50 to 60,000 people die of snake bite each year
90% from Asia and Africa
First Aid
Do it RIGHT
Symptoms of Envenomation
Neurological impairment
ptosis, muscle weakness, respiratory
distress/arrest
Hematological
bleeding from bite site, epistaxis,
hemoptysis, hematuria, ecchymosis
Painful Progressive Swelling
Feature
Cobras Kraits
Russells
Viper
Saw Scaled
Viper
Hump
Nosed
Viper
YES
NO
YES
YES
YES
Ptosis/ Neurological
Signs
YES
YES
YES!
NO
NO
Haemostatic
abnormalities
NO
NO!
YES
YES
YES
Renal Complications
NO
NO
YES
NO
YES
Response to Neostigmine
YES
NO?
NO?
NO
NO
Response to ASV
YES
YES
YES
YES
NO
Late-onset envenoming
Krait and viper can take 6 to 12hrs
Juvenile snakes, 8-10 inches long
Simpson ID. Snakebite Management in India, The First Few Hours: A Guide
for Primary Care Physicians. J Indian Med Assoc 2007;105:324-335
Other Investigations
Hb/ PCV/ Platelet Count/ PT/ APTT/ FDP
D-Dimer
Peripheral Smear
Urine for Protein/ RBC/ Haemoglobinuria/
Myoglobinuria
Serum Creat / Urea/ Potassium
Management
Initial resuscitation
Pain management
Antisnake venom (ASV)
Supportive treatment
Treatment of complications
Pain management
Paracetamol
Opiates like Tramadol
Avoid aspirin/NSAIDs
TOXIC COMPONENTS OF
SNAKE VENOM
Protein components: 90-95%
Consist of Enzymes (Phospholipase
A2,Proteolytic enzymes,Hyaluronidase)
Polypeptides Pre-synaptic (Beta-bungarotoxin)
Post-synaptic (Alpha) neurotoxins (Bungarotoxin
and cobrotoxins)
Non-protein components: 5-10%
ASV Preparation
Liquid:
2yr shelf life, reliable cold chain,
no reconstitution
Lyophilised:
5 yr shelf life, no cold chain,
30 60 mins to reconstitute
ASV Dosage
Russells Viper injects on average 63mg SD 7 mg of
venom. Range 5mg 147 mg.
Each ASV vial neutralises 6mg of venom.
Initial dose should neutralise the average dose of
venom injected.(10 vials)
Total required dose between 10 to 25 vials
ASV dosage
Neurotoxic/ Anti Haemostatic 8-10 Vials
Ghosh S, Maisnam I, Murmu BK, Mitra PK, Roy A, Simpson ID. A locally
developed snakebite management protocol significantly reduces overall anti
snake venom utilization in West Bengal, India. Wilderness Environ Med;
2008;19;267-74
Local envenoming
Local swelling involving more than half of the bitten
limb (in the absence of a tourniquet).
Rapid extension of swelling
Development of an enlarged tender lymph node
draining the bitten limb.
ASV in pregnancy
Dosage is the same
Greatest risk in 1st trimester with coagulopathy
Spontaneous abortions can occur within 7 days
of the bite
ASV in children
Snake injects the same amount of venom
whether it is a child or adult.
Hence the dose of antivenom remains the same
Recovery Phase
If an adequate dose of antivenom has been given
systemic bleeding stops within 15-30 mins &
coagulability is restored in 6 hrs.
Post synaptic neurotoxic envenoming (Cobra) may
begin to improve as early as 30 mins after antivenom.
Presynaptic neurotoxic envenoming (Krait) usually
takes a longer time.
In hypotension, BP may increase after 30 mins
Recurrent Envenomation
Once coagulopathy settles no further ASV
should be administered, unless a proven
recurrence of a coagulation abnormality is
established.
Prophylactic ASV not indicated to prevent
recurrence
Indian ASV is a F(ab)2 product and has a halflife of over 90 hours
Antivenom Reactions
20%of patients
Early (within 10 to 180 mins)
Late ( 5 days or more)
Pathophysiology
Complement mediated anaphylactic reaction.
Not IgE mediated
ASV Reactions
ASV Reactions
Persistent hypotension,
Life threatening anaphylaxis
Adrenaline 0.2mg(200ug) of 1:10,000
dilution, IV bolus
Repeat if necessary
If hypotension refractory to bolus dose start
an adrenaline infusion
Immediate Management of Airway &
Breathing
Epinephrine infusion
1mg epinephrine in 500ml of 5%D / NS
1-4ug/min (0.5 to 2ml/ min)
Titrate to effect
Treatment of Hypotension
Crystalloids NS bolus 1-2L
(10 to 20ml/kg in children)
SECOND- LINE THERAPY Corticosteroids
Hydrocortisone 200 500mg IV
(5-10mg/kg in children)
Methylprednisolone 125mg IV
(2mg/kg in children)
Prevents recurrent anaphylaxis
For allergic
bronchospasm
Nebulization
Salbutamol+ipratopium
bromide
Nebulised adrenaline if
required
Additional Treatment
H1 antihistamine,
10mg chlorpheniramine maleate IV,
(0.2mg/kg children) or
22.5mg pheniramine maleate IV or
25mg promethazine HCl IV
H2 antihistamines,
Ranitidine 50mg IV
No absolute contraindications to
antivenom
Patients with previous reactions to
antitetanus, antirabies serum
Atopic diseases like severe asthma
Give only with systemic envenomation
Prophylactic regimes can be used
Repeat bite
Dosage and schedule of ASV remains
the same
Higher risk of adverse reactions
Prophylactic regimes can be used
Supportive management
of snake bite victims
Neurotoxic envenomation
Bulbar and respiratory paralysis.
Aspiration, airway obstruction or
respiratory failure.
Intubate and mechanically ventilate.
Neurotoxic Envenomation-Role of
Neostigmine
An anticholinesterase like Neostigmine prolongs
the life of acetylcholine and can reverse the
respiratory failure and neurotoxic symptoms due
to snake venom.
Neostigmine TEST:
1.5-2.0 mg neostigmine with 0.6mg atropine IV
Observe for 1 hr
Haemostatic abnormalities:
Strict bed rest to avoid even minor trauma
Transfusion of FFP, cryoprecipitate, platelet
concentrates, or even fresh whole blood can
be life saving.
Avoid intramuscular injections
Renal failure
Dialyze if necessary.
Treat the Hyperkalemia
Bacterial infections:
Infection at the site of the bite is common.
Broad spectrum antibiotics
Anti-tetanus toxoid
Surgical Intervention
Debridement of necrotic tissue
Fasciotomy for intracompartmental
syndrome
Handling Tourniquets
Sudden removal can lead to a massive surge of
venom leading to neurological paralysis,
hypotension.
IV line, O2, to handle above complications
To Summarize